Please login to the form below

Not currently logged in

Chiltern hires Roche’s Andrew Monaghan to head pharmacovigilance

He was global head of safety operations at pharma company

Roche's Andrew Monaghan has swapped pharma for clinical research by moving to Chiltern.

Monaghan, who was global head of safety operations at Roche, take on the role of director of global pharmacovigilance at the clinical research organisation Chiltern.

In this new role, he will lead Chiltern's pharmacovigilance team and expand the organisation's global pharmacovigilance offering.

“His strong leadership skills and extensive clinical experience will ensure our clients continue to receive customized and efficient safety solutions to meet their specific product and regulatory requirements, whether with investigational or postmarketed products,” said Dr Sharon Moore, executive VP, global medical and regulatory affairs.

Monaghan has served at Roche since 1997, when he joined as global head of PDO clinical management group.

Prior to this role he was director of regulatory affairs at Pfizer Global Research & Development.

25th July 2013


Featured jobs

Subscribe to our email news alerts


Add my company
FCB Halesway

A Eureka moment! A converted dairy in the Hampshire countryside back in 1993 saw the inception of Halesway as a...

Latest intelligence

When is it time to rebrand?
The Biosimilar Challenge
How health behaviours and clinical outcomes are related
When HCPs understand patient activation levels they can actively guide patients towards more confident self-management of diverse health concerns....